123 related articles for article (PubMed ID: 8041153)
21. Activation of T-cells by bryostatins: induction of the IL-2 receptor gene transcription and down-modulation of surface receptors.
Esa AH; Boto WO; Adler WH; May WS; Hess AD
Int J Immunopharmacol; 1990; 12(5):481-90. PubMed ID: 2210911
[TBL] [Abstract][Full Text] [Related]
22. Rapid generation of potent and tumor-specific cytotoxic T lymphocytes by interleukin 18 using dendritic cells and natural killer cells.
Tanaka F; Hashimoto W; Okamura H; Robbins PD; Lotze MT; Tahara H
Cancer Res; 2000 Sep; 60(17):4838-44. PubMed ID: 10987295
[TBL] [Abstract][Full Text] [Related]
23. Cytolytic T lymphocyte precursor cells in congenitally athymic C57BL/6 nu/nu mice: quantitation, enrichment, and specificity.
Maryanski JL; MacDonald HR; Sordat B; Cerottini JC
J Immunol; 1981 Mar; 126(3):871-6. PubMed ID: 6450805
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of PMA-induced human T cell proliferation by bryostatin is associated with enhanced degradation of conventional protein kinase C (cPKC): Ca2+ signals restore mitogenic activity without abrogating enhanced cPKC degradation.
Galron D; Tamir A; Altman A; Isakov N
Cell Immunol; 1994 Oct; 158(1):195-207. PubMed ID: 8087865
[TBL] [Abstract][Full Text] [Related]
25. Effects of gamma-irradiation on lymphocyte subpopulations participating in the development of the cytotoxic T lymphocyte response.
Susskind BM; Faanes RB
J Immunol; 1981 Oct; 127(4):1485-9. PubMed ID: 6974194
[TBL] [Abstract][Full Text] [Related]
26. Generation of alloreactive cytotoxic T lymphocytes: evidence for a differentiation factor distinct from IL 2.
Finke JH; Scott J; Gillis S; Hilfiker ML
J Immunol; 1983 Feb; 130(2):763-7. PubMed ID: 6600253
[TBL] [Abstract][Full Text] [Related]
27. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
Utermöhlen O; Schulze-Garg C; Warnecke G; Gugel R; Löhler J; Deppert W
J Virol; 2001 Nov; 75(22):10593-602. PubMed ID: 11602701
[TBL] [Abstract][Full Text] [Related]
28. Bryostatin-1 and IFN-gamma synergize for the expression of the inducible nitric oxide synthase gene and for nitric oxide production in murine macrophages.
Taylor LS; Cox GW; Melillo G; Bosco MC; Espinoza-Delgado I
Cancer Res; 1997 Jun; 57(12):2468-73. PubMed ID: 9192827
[TBL] [Abstract][Full Text] [Related]
29. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
30. Photochemical treatment with S-59 psoralen and ultraviolet A light to control the fate of naive or primed T lymphocytes in vivo after allogeneic bone marrow transplantation.
Truitt RL; Johnson BD; Hanke C; Talib S; Hearst JE
J Immunol; 1999 Nov; 163(9):5145-56. PubMed ID: 10528221
[TBL] [Abstract][Full Text] [Related]
31. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
[TBL] [Abstract][Full Text] [Related]
32. Immunization with wild-type p53 gene sequences coadministered with Flt3 ligand induces an antigen-specific type 1 T-cell response.
Parajuli P; Pisarev V; Sublet J; Steffel A; Varney M; Singh R; LaFace D; Talmadge JE
Cancer Res; 2001 Nov; 61(22):8227-34. PubMed ID: 11719454
[TBL] [Abstract][Full Text] [Related]
33. Central role of tumor-associated CD8+ T effector/memory cells in restoring systemic antitumor immunity.
Kilinc MO; Gu T; Harden JL; Virtuoso LP; Egilmez NK
J Immunol; 2009 Apr; 182(7):4217-25. PubMed ID: 19299720
[TBL] [Abstract][Full Text] [Related]
34. Peripheral (somatic) expansion of the murine cytotoxic T lymphocyte repertoire. I. Analysis of diversity in recognition repertoire of alloreactive T cells derived from the thymus and spleen of adult or aged DBA/2J mice.
Chang MP; Gorczynski RM
J Immunol; 1984 Nov; 133(5):2375-80. PubMed ID: 6332848
[TBL] [Abstract][Full Text] [Related]
35. Absence of major histocompatibility complex class I on neural stem cells does not permit natural killer cell killing and prevents recognition by alloreactive cytotoxic T lymphocytes in vitro.
Mammolenti M; Gajavelli S; Tsoulfas P; Levy R
Stem Cells; 2004; 22(6):1101-10. PubMed ID: 15536199
[TBL] [Abstract][Full Text] [Related]
36. Development of CD8+ effector T cells is differentially regulated by IL-18 and IL-12.
Okamoto I; Kohno K; Tanimoto T; Ikegami H; Kurimoto M
J Immunol; 1999 Mar; 162(6):3202-11. PubMed ID: 10092771
[TBL] [Abstract][Full Text] [Related]
37. Stimulation of tumor-draining lymph node cells with superantigenic staphylococcal toxins leads to the generation of tumor-specific effector T cells.
Shu S; Krinock RA; Matsumura T; Sussman JJ; Fox BA; Chang AE; Terman DS
J Immunol; 1994 Feb; 152(3):1277-88. PubMed ID: 8301131
[TBL] [Abstract][Full Text] [Related]
38. T-cells for tumor therapy can be obtained from antigen-loaded sponge implants.
Chen W; Reese VA; Cheever MA
Cancer Res; 1994 Feb; 54(4):1065-70. PubMed ID: 8313363
[TBL] [Abstract][Full Text] [Related]
39. Clonal analysis of T cell unresponsiveness to alloantigens induced by neonatal injection of F1 spleen cells into parental mice.
Feng HM; Glasebrook AL; Engers HD; Louis JA
J Immunol; 1983 Nov; 131(5):2165-9. PubMed ID: 6195253
[TBL] [Abstract][Full Text] [Related]
40. Phenotypic characteristics associated with the acquisition of HSV-specific CD8 T-lymphocyte-mediated cytolytic function in vitro.
McNally JM; Andersen HA; Chervenak R; Jennings SR
Cell Immunol; 1999 May; 194(1):103-11. PubMed ID: 10357886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
